Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
Ravi Savarirayan*, William R. Wilcox, Paul Harmatz, John Phillips, Lynda E. Polgreen, Louise Tofts, Keiichi Ozono, Paul Arundel, Melita Irving, Carlos A. Bacino, Donald Basel, Michael B. Bober, Joel Charrow, Hiroshi Mochizuki, Yumiko Kotani, Howard M. Saal, Clare Army, George Jeha, Yulan Qi, Lynn HanElena Fisheleva, Alice Huntsman-Labed, Jonathan Day
Dive into the research topics of 'Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial'. Together they form a unique fingerprint.